C
IPSC
Century Therapeutics, Inc.
2.320
+0.020+0.87%After Hours: 2.360 +0.040 +1.72%18:51 06/26 EDT
OPEN/PREV CLOSE2.280/2.300
TODAY RANGE2.270-2.500
VOL17.00M
MARKET CAP418.42M
52 WEEK RANGE0.4350-3.040
AVG VOL (3M)1.23M
% TURNOVER9.42%
TURNOVER--
P/E (TTM)-2.0959
% RANGE9.78%
EPS(TTM)-1.1069
P/E(FORWARD)-5.0435
P/B1.578
BVPS1.470
DIVIDEND--
P/S1.860
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP384.05M
SHARES OUTSTANDING180.35M
NEXT EARNINGS08/03-08/14
FREE FLOAT165.54M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·12h ago
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday
TipRanks·06/12 21:03
Century Therapeutics Shareholders Approve Directors and Share Increase
TipRanks·06/10 00:45
Century Therapeutics (IPSC) Receives a Buy from Mizuho Securities
TipRanks·06/09 11:18
Piper Sandler Reaffirms Their Buy Rating on Century Therapeutics (IPSC)
Seeking Alpha·06/09 09:18
Quant rating check: Top oncology peers as Nuvalent goes private in $10.6B deal with GSK
TipRanks·06/08 20:40
Century Therapeutics presents new preclinical data for CNTY-813
TipRanks·06/08 20:34
Century Therapeutics Advances CNTY-813 Diabetes Cell Therapy
Seeking Alpha·06/08 14:59
These healthcare stocks have maintained Strong Buy ratings for months
Benzinga·06/08 12:04
Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.